Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0XKMVA
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
CRB-701
|
|||||
| Synonyms |
CRB-701; CRB-701, SYS6002; SYS 6002; SYS-6002; SYS6002
Click to Show/Hide
|
|||||
| Organization |
CSPC Jushi Biomedicine Co., Ltd.; Corbus Pharmaceuticals, Inc.
|
|||||
| Drug Status |
Phase 1/2
|
|||||
| Indication |
In total 1 Indication(s)
|
|||||
| Drug-to-Antibody Ratio |
2
|
|||||
| Structure |
|
|||||
| Antibody Name |
Undisclosed
|
|||||
| Antigen Name |
Nectin-4 (NECTIN4)
|
Antigen Info | ||||
| Payload Name |
Monomethyl auristatin E
|
Payload Info | ||||
| Therapeutic Target |
Microtubule (MT)
|
Target Info | ||||
| Linker Name |
NH2-PEG3-Val-Cit-PABC
|
Linker Info | ||||
| Conjugate Type |
Enzymatic Catalysis
|
|||||
| Combination Type |
LND1002
|
|||||
